A series of recent pre-clinical reports demonstrates LB-100’s effectiveness in variousnon-neoplastic diseases that may benefit from PP2A inhibition PASADENA, CA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- ...
A new innovation agenda released by the Food and Drug Administration's Center for Veterinary Medicine outlines how CVM plans to address hot-button issues such as approvals of zootechnical feed ...
SILVER SPRING, Md., Sept. 15, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it is taking new steps to further modernize its approach to evaluating and supporting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results